|
Q3 2022
Filed on Nov 14, 2022
|
30,501
|
$51.03 - $264.23
$1.56M - $8.06M
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
101,905
|
$170.95 - $234.04
$17.4M - $23.8M
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
717
|
$211.07 - $260.94
$151K - $187K
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
457
|
$181.5 - $220.22
$82.9K - $101K
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
120,651
|
N/A
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
864
|
$162.7 - $204.12
$141K - $176K
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
5,896
|
N/A
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
66,291
|
N/A
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
1,874,792
|
$16.49 - $25.64
$30.9M - $48.1M
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
486,217
|
$78.4 - $102.45
$38.1M - $49.8M
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
53
|
$20.45 - $29.09
$1.08K - $1.54K
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
373,424
|
$18.8 - $35.27
$7.02M - $13.2M
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
560,769
|
$18.79 - $80.99
$10.5M - $45.4M
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
238
|
$38.52 - $45.03
$9.17K - $10.7K
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
358
|
$53.86 - $66.8
$19.3K - $23.9K
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
1,562
|
N/A
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
184,426
|
$0.13 - $76.84
$24K - $14.2M
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
2,977
|
$35.5 - $43.28
$106K - $129K
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
4,081
|
$28.18 - $33.1
$115K - $135K
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
2,022
|
N/A
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
375
|
$303.35 - $492.74
$114K - $185K
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
266,046
|
$26.8 - $34.23
$7.13M - $9.11M
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
1,605
|
$436.56 - $524.08
$701K - $841K
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
726,700
|
$135.94 - $164.63
$98.8M - $120M
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
2,816,599
|
$4.56 - $7.06
$12.8M - $19.9M
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
384,753
|
$174.74 - $202.41
$67.2M - $77.9M
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
274,715
|
N/A
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
10,663
|
$40.0 - $49.37
$427K - $526K
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
1,197,424
|
$27.25 - $52.59
$32.6M - $63M
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
16,747
|
$1.05 - $2.85
$17.6K - $47.7K
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
43,171
|
$176.26 - $208.9
$7.61M - $9.02M
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
834,850
|
$24.23 - $70.23
$20.2M - $58.6M
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
6,358
|
$56.02 - $65.22
$356K - $415K
|
|
Celldex Therapeutics Inc New
|
Q3 2022
Filed on Nov 14, 2022
|
118,969
|
N/A
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
9,629
|
N/A
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
413
|
N/A
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
15,575
|
N/A
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
2,202
|
N/A
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
411
|
$853.05 - $1452.32
$351K - $597K
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
2,339,900
|
$25.32 - $32.23
$59.2M - $75.4M
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
1,036,574
|
N/A
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
326,530
|
$31.75 - $45.29
$10.4M - $14.8M
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
461,495
|
$52.69 - $63.7
$24.3M - $29.4M
|
|
Calithera Biosciences Inc
|
Q3 2022
Filed on Nov 14, 2022
|
41,666
|
N/A
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
3,886
|
N/A
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
665,718
|
$19.08 - $114.76
$12.7M - $76.4M
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
27,635
|
$8.24 - $12.56
$228K - $347K
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
1,145
|
$52.25 - $71.32
$59.8K - $81.7K
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
530
|
$7.03 - $11.19
$3.73K - $5.93K
|
|
|
Q3 2022
Filed on Nov 14, 2022
|
452,656
|
$25.35 - $39.06
$11.5M - $17.7M
|
|